Fushine(SZ:300497) Zheng Quan Zhi Xing·2025-06-27 16:48Core Viewpoint - Jiangxi Fuxiang Pharmaceutical Co., Ltd. is revising its Articles of Association and management systems, including a significant change in the use of repurchased shares from employee stock ownership plans to capital reduction through share cancellation [1][2]. Summary by Sections Revision of Articles of Association - The company plans to change the purpose of 11,355,900 repurchased shares from "for employee stock ownership plans or equity incentives" to "for cancellation and reduction of registered capital" [1]. - Following this cancellation and capital reduction, the total share capital will decrease from 550,004,834 shares to 538,648,934 shares, and the registered capital will change from RMB 550,004,834 to RMB 538,648,934 [1]. Management System Development - The company is establishing a board member departure management system to ensure accountability for unfulfilled public commitments and other outstanding matters [2]. - Additionally, the company is creating an information disclosure deferral and exemption management system to clarify internal review procedures for such disclosures [2]. Modification of Existing Management Systems - The company is updating several governance systems in accordance with the latest revisions of relevant laws and regulations, including the Articles of Association and information disclosure management [3]. - Specific modifications include changes to the "Rules of Procedure for Shareholders' Meetings," "Rules of Procedure for Board Meetings," "Independent Director Work System," "Related Party Transaction Management System," and "Director Allowance Management System," which will also require shareholder meeting approval [3].